SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013560
Filing Date
2022-08-15
Accepted
2022-08-15 07:09:46
Documents
45
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q plx-20220630x10q.htm   iXBRL 10-Q 966608
2 EX-3.5 plx-20220630xex3d5.htm EX-3.5 9573
3 EX-31.1 plx-20220630xex31d1.htm EX-31.1 10030
4 EX-31.2 plx-20220630xex31d2.htm EX-31.2 10390
5 EX-32.1 plx-20220630xex32d1.htm EX-32.1 6123
6 EX-32.2 plx-20220630xex32d2.htm EX-32.2 6149
7 GRAPHIC plx-20220630x10q005.jpg GRAPHIC 113571
8 GRAPHIC plx-20220630x10q006.jpg GRAPHIC 100730
9 GRAPHIC plx-20220630x10q007.jpg GRAPHIC 35810
  Complete submission text file 0001558370-22-013560.txt   4127230

Data Files

Seq Description Document Type Size
10 EX-101.SCH plx-20220630.xsd EX-101.SCH 27312
11 EX-101.CAL plx-20220630_cal.xml EX-101.CAL 34234
12 EX-101.DEF plx-20220630_def.xml EX-101.DEF 127031
13 EX-101.LAB plx-20220630_lab.xml EX-101.LAB 207593
14 EX-101.PRE plx-20220630_pre.xml EX-101.PRE 192712
39 EXTRACTED XBRL INSTANCE DOCUMENT plx-20220630x10q_htm.xml XML 402552
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 221162288
SIC: 2836 Biological Products, (No Diagnostic Substances)